AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glybir Plus G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Brilliant Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glybir Plus G1 Tablet SR

G1 Plus Glybir SR tablets are classified as antidiabetic medications. This dual-drug formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect. Learn to identify its symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures. Maintain regular meals and carry readily-available glucose sources, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your physician may order blood tests to track blood cell counts and liver function.

Uses of Glybir Plus G1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glybir Plus G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glybir Plus G1 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. This medication should be taken with food.

Common Side effects of Glybir Plus G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glybir Plus G1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glybir Plus G1 Tablet SR should be administered with a meal.

How Glybir Plus G1 Tablet SR works:

Glybir Plus G1 Tablet SR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glybir Plus G1 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glybir Plus G1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. It is crucial to seek medical advice.

Breast feedingBreast feedingUNSAFE

Glybir Plus G1 sustained-release tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when prescribing Glybir Plus G1 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glybir Plus G1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glybir Plus G1 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glybir Plus G1 Tablet SR :

Should you forget a Glybir Plus G1 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glybir Plus G1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glybir Plus G1 Tablet SR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Glybir Plus G1 Tablet SR use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Glybir Plus G1 Tablet SR and prompt medical attention.
Glybir Plus G1 SR tablets contain glimepiride and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This treatment improves glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride enhances pancreatic insulin secretion, thereby reducing blood glucose. Metformin functions by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glybir Plus G1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Glybir Plus G1 Tablet SR may induce Vitamin B12 deficiency with prolonged administration. This medication inhibits Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency can lead to anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. Prophylactic Vitamin B12 supplementation, at least annually, has been proposed by some investigators to mitigate these risks.
Glybir Plus G1 Tablet SR can indeed lower blood sugar, leading to hypoglycemia. This condition manifests as nausea, headache, irritability, hunger pangs, sweating, dizziness, a rapid pulse, and feelings of anxiety or trembling. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other diabetes medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glybir Plus G1 Tablet SR and alcohol is unsafe. Concurrent use may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glybir Plus G1 Tablet SR
48
MRP 58
17% off